North America Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Country: Trend Forecast and Growth Opportunity
- GRA4881403
- 108 Pages
- February 2022
- Healthcare
Highlighted with 23 tables and 58 figures, this 108-page report “North America Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America clinical diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America clinical diagnostics market in every aspect of the classification from perspectives of by Test, Product, Indication, Patient Gender, Age Group, End User, and Country.
Based on Test, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Lipid Panel
• Infectious Disease Testing
• Liver Panel
• Complete Blood Count (CBC)
• Electrolyte Testing
• Renal Panel
• Other Tests
Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Assay Kits & Reagents
• Software & Services
By Indication the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Cardiovascular
• Cancer
• Infectious Disease
• Stroke
• Chronic Lower Respiratory Diseases
• Diabetes
• Other Indications
By Patient Gender the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Male Patients
• Female Patients
By Age Group the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Age 44 and below
• Age 45-64
• Age 65 and over
By End User the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospital & Clinics Laboratory
• Diagnostic Laboratory
• Point-of-Care Testing
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis, and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Test, Product, and Indication over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
• Abbott Laboratories
• Becton, Dickinson and Company
• BioMerieux SA
• Bio-Rad Laboratories Inc.
• Bio-Reference Laboratories
• Bioscientia Healthcare
• Charles River Laboratories
• Danaher Corporation
• Hoffmann-La Roche AG
• Hologic Inc.
• Qiagen NV
• Siemens Healthcare
• Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter’s Fiver Forces Analysis 37
3 Segmentation of North America Market by Test 41
3.1 Market Overview by Test 41
3.2 Lipid Panel 43
3.3 Infectious Disease Testing 44
3.4 Liver Panel 45
3.5 Complete Blood Count (CBC) 46
3.6 Electrolyte Testing 47
3.7 Renal Panel 48
3.8 Other Tests 49
4 Segmentation of North America Market by Product 50
4.1 Market Overview by Product 50
4.2 Instruments 52
4.3 Assay Kits & Reagents 53
4.4 Software & Services 54
5 Segmentation of North America Market by Indication 55
5.1 Market Overview by Indication 55
5.2 Cardiovascular 57
5.3 Cancer 58
5.4 Infectious Disease 59
5.5 Stroke 60
5.6 Chronic Lower Respiratory Diseases 61
5.7 Diabetes 62
5.8 Other Indications 63
6 Segmentation of North America Market by Patient Gender 64
6.1 Market Overview by Patient Gender 64
6.2 Male Patients 66
6.3 Female Patients 67
7 Segmentation of North America Market by Age Group 68
7.1 Market Overview by Age Group 68
7.2 Age 44 and below 70
7.3 Age 45-64 71
7.4 Age 65 and over 72
8 Segmentation of North America Market by End User 73
8.1 Market Overview by End User 73
8.2 Hospital & Clinics Laboratory 75
8.3 Diagnostic Laboratory 76
8.4 Point-of-Care Testing 77
8.5 Other End Users 78
9 North America Market 2021-2031 by Country 79
9.1 Overview of North America Market 79
9.2 U.S. 82
9.3 Canada 86
9.4 Mexico 88
10 Competitive Landscape 90
10.1 Overview of Key Vendors 90
10.2 New Product Launch, Partnership, Investment, and M&A 93
10.3 Company Profiles 94
Abbott Laboratories 94
Becton, Dickinson and Company 96
BioMerieux SA 97
Bio-Rad Laboratories Inc. 98
Bio-Reference Laboratories 99
Bioscientia Healthcare 100
Charles River Laboratories 101
Danaher Corporation 102
Hoffmann-La Roche AG 103
Hologic Inc. 104
Qiagen NV 105
Siemens Healthcare 106
Thermo Fisher Scientific 107
RELATED REPORTS 108
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 29
Table 4. Main Product Trends and Market Opportunities in North America Clinical Diagnostics Market 33
Table 5. North America Clinical Diagnostics Market by Test, 2021-2031, $ mn 41
Table 6. North America Clinical Diagnostics Market by Product, 2021-2031, $ mn 50
Table 7. North America Clinical Diagnostics Market by Indication, 2021-2031, $ mn 55
Table 8. North America Clinical Diagnostics Market by Patient Gender, 2021-2031, $ mn 64
Table 9. North America Clinical Diagnostics Market by Age Group, 2021-2031, $ mn 68
Table 10. North America Clinical Diagnostics Market by End User, 2021-2031, $ mn 73
Table 11. North America Clinical Diagnostics Market by Country, 2021-2031, $ mn 80
Table 12. U.S. Clinical Diagnostics Market by Test, 2021-2031, $ mn 85
Table 13. U.S. Clinical Diagnostics Market by Product, 2021-2031, $ mn 85
Table 14. U.S. Clinical Diagnostics Market by Indication, 2021-2031, $ mn 85
Table 15. Canada Clinical Diagnostics Market by Test, 2021-2031, $ mn 87
Table 16. Canada Clinical Diagnostics Market by Product, 2021-2031, $ mn 87
Table 17. Canada Clinical Diagnostics Market by Indication, 2021-2031, $ mn 87
Table 18. Mexico Clinical Diagnostics Market by Test, 2021-2031, $ mn 89
Table 19. Mexico Clinical Diagnostics Market by Product, 2021-2031, $ mn 89
Table 20. Mexico Clinical Diagnostics Market by Indication, 2021-2031, $ mn 89
Table 21. Abbott Laboratories: Company Snapshot 94
Table 22. Abbott Laboratories: Business Segmentation 95
Table 23. Abbott Laboratories: Product Portfolio 95
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
